Literature DB >> 23406790

Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis of 1731 cases.

Laert Oliveira de Andrade Filho1, Sérgio Kuzniec, Nelson Wolosker, Guilherme Yazbek, Paulo Kauffman, José Ribas Milanez de Campos.   

Abstract

BACKGROUND: The aim of this study was to ascertain the technical difficulties and complications of video-assisted thoracic sympathectomy (VTAS) in the treatment of hyperhidrosis in a large group of patients.
METHODS: Between October 1995 and February 2008, 1731 patients with palmar, axillary, or craniofacial hyperhidrosis, who were treated using bilateral VTAS, were studied. We assessed the technical difficulties, early and late complications, and the approaches that were used to resolve them.
RESULTS: Therapeutic success was achieved in 91% of the cases as evidenced by anhidrosis. The most common and severe technical difficulty during the procedure was pleural adhesions in 116 cases (6.7%); azygos lobes were seen in 7 patients (0.4%) and apical blebs in 3 patients (0.2%). The most frequent postoperative immediate complication was postoperative pain in 1685 (97.4%) patients; pneumothorax with chest drainage was seen in 60 cases (3.5%), neurologic disorders involving the upper limbs in 36 cases (2.1%), Horner's syndrome in 11 cases (0.9%), significant bleeding in 8 cases (0.4%), and 1 patient had extensive subcutaneous emphysema. The most frequent late complication was compensatory hyperhidrosis, which occurred in 1531 cases (88.4%). Although 27.2% of the patients reported severe compensatory hyperhidrosis, only 2.5% expressed regret for undergoing surgery. Gustatory sweating occurred in 334 patients (19.3%). No deaths occurred in this series.
CONCLUSIONS: VTAS is safe and has shown good results. The major complication is compensatory hyperhidrosis and, when severe, the patient may express regret for undergoing surgery. Improvements in instrumentation, adequate training, and careful patient selection may help to reduce the number of drawbacks associated with VTAS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23406790     DOI: 10.1016/j.avsg.2012.05.026

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  8 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 2.  Regret in Surgical Decision Making: A Systematic Review of Patient and Physician Perspectives.

Authors:  Ana Wilson; Sean M Ronnekleiv-Kelly; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

3.  Long-term results of oxybutynin use in treating facial hyperhidrosis.

Authors:  Nelson Wolosker; Marcelo Passos Teivelis; Mariana Krutman; Taiz Pereira Dozono de Almeida Campbell; Paulo Kauffman; José Ribas de Campos; Pedro Puech-Leão
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

4.  Long-term results of oxybutynin treatment for palmar hyperhidrosis.

Authors:  Nelson Wolosker; Marcelo Passos Teivelis; Mariana Krutman; Rafael P de Paula; José R M de Campos; Paulo Kauffman; Pedro Puech-Leão
Journal:  Clin Auton Res       Date:  2014-11-27       Impact factor: 4.435

Review 5.  Video-assisted thoracic surgery complications.

Authors:  Mariusz P Łochowski; Józef Kozak
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-07-23       Impact factor: 1.195

6.  Thoracic sympathectomy for peripheral vascular disease can lead to severe bronchospasm and excessive bronchial secretions.

Authors:  Vikas Deep Goyal; Bharti Gupta; Sanjeev Kumar; Sanjay Pal
Journal:  Lung India       Date:  2015 Jan-Feb

7.  Epidemiologic analysis of prevalence of the hyperhidrosis.

Authors:  Fernanda Alvarenga Estevan; Marina Borri Wolosker; Nelson Wolosker; Pedro Puech-Leão
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

8.  Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years.

Authors:  Nelson Wolosker; Mariana Krutman; Marcelo Passos Teivelis; Rafael Pessanha de Paula; Paulo Kauffman; Jose Ribas Milanez de Campos; Pedro Puech-Leão
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.